ZOOMER Magazine - - ADVOCACY -

WHEN PRIME MIN­IS­TER Justin Trudeau an­nounced in an in­ter­view with Zoomer mag­a­zine (Oc­to­ber 2018) that a na­tional pharmacare plan was “com­ing,” he touched off spec­u­la­tion that the Lib­er­als would of­fer it as a big-ticket item in their plat­form for the 2019 fed­eral elec­tion. In an ef­fort to shape this drug plan, CARP has joined with more than 70 na­tional, pro­vin­cial and ter­ri­to­rial or­ga­ni­za­tions (rep­re­sent­ing health-care providers, non-profit or­ga­ni­za­tions, work­ers, se­niors, pa­tients and aca­demics) in com­ing to a con­sen­sus about the prin­ci­ples that must un­der­pin a na­tional pharmacare pro­gram in the coun­try. The Pharmacare Con­sen­sus Prin­ci­ple states that any na­tional drug plan must be gov­erned by the fol­low­ing val­ues: uni­ver­sal­ity; pub­lic, sin­gle-payer ad­min­is­tra­tion; ac­ces­si­bil­ity; com­pre­hen­sive­ness; por­ta­ble cov­er­age. “A uni­ver­sal, sin­gle-payer pharmacare pro­gram will not only en­sure all Cana­di­ans have ac­cess to the med­i­ca­tions they need,” says Wanda Mor­ris, CARP’s chief ad­vo­cacy and en­gage­ment officer, “it will pro­vide bil­lions of dol­lars in net sav­ings to busi­nesses, in­di­vid­u­als and the gov­ern­ment.”

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.